This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment

Clinical trial NCT00150800 · COMPLETED

Trial details

NCT number

NCT00150800

Sponsor

UCB PHARMA Inc. (US)

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2006-01-01

Primary completion

2017-09-01

Enrollment

668

View on ClinicalTrials.gov